Cargando…

Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity

BACKGROUND: Integrins are known to be important contributors to cancer progression. We have previously shown that the integrin β4 subunit is up-regulated in primary colon cancer. Its partner, the integrin α6 subunit, exists as two different mRNA splice variants, α6A and α6B, that differ in their cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Dydensborg, Anders Bondo, Teller, Inga C, Groulx, Jean-François, Basora, Nuria, Paré, Fréderic, Herring, Elizabeth, Gauthier, Rémy, Jean, Dominique, Beaulieu, Jean-François
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715428/
https://www.ncbi.nlm.nih.gov/pubmed/19586553
http://dx.doi.org/10.1186/1471-2407-9-223
_version_ 1782169778755993600
author Dydensborg, Anders Bondo
Teller, Inga C
Groulx, Jean-François
Basora, Nuria
Paré, Fréderic
Herring, Elizabeth
Gauthier, Rémy
Jean, Dominique
Beaulieu, Jean-François
author_facet Dydensborg, Anders Bondo
Teller, Inga C
Groulx, Jean-François
Basora, Nuria
Paré, Fréderic
Herring, Elizabeth
Gauthier, Rémy
Jean, Dominique
Beaulieu, Jean-François
author_sort Dydensborg, Anders Bondo
collection PubMed
description BACKGROUND: Integrins are known to be important contributors to cancer progression. We have previously shown that the integrin β4 subunit is up-regulated in primary colon cancer. Its partner, the integrin α6 subunit, exists as two different mRNA splice variants, α6A and α6B, that differ in their cytoplasmic domains but evidence for distinct biological functions of these α6 splice variants is still lacking. METHODS: In this work, we first analyzed the expression of integrin α6A and α6B at the protein and transcript levels in normal human colonic cells as well as colorectal adenocarcinoma cells from both primary tumors and established cell lines. Then, using forced expression experiments, we investigated the effect of α6A and α6B on the regulation of cell proliferation in a colon cancer cell line. RESULTS: Using variant-specific antibodies, we observed that α6A and α6B are differentially expressed both within the normal adult colonic epithelium and between normal and diseased colonic tissues. Proliferative cells located in the lower half of the glands were found to predominantly express α6A, while the differentiated and quiescent colonocytes in the upper half of the glands and surface epithelium expressed α6B. A relative decrease of α6B expression was also identified in primary colon tumors and adenocarcinoma cell lines suggesting that the α6A/α6B ratios may be linked to the proliferative status of colonic cells. Additional studies in colon cancer cells showed that experimentally restoring the α6A/α6B balance in favor of α6B caused a decrease in cellular S-phase entry and repressed the activity of c-Myc. CONCLUSION: The findings that the α6Bβ4 integrin is expressed in quiescent normal colonic cells and is significantly down-regulated in colon cancer cells relative to its α6Aβ4 counterpart are consistent with the anti-proliferative influence and inhibitory effect on c-Myc activity identified for this α6Bβ4 integrin. Taken together, these findings point out the importance of integrin variant expression in colon cancer cell biology.
format Text
id pubmed-2715428
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27154282009-07-25 Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity Dydensborg, Anders Bondo Teller, Inga C Groulx, Jean-François Basora, Nuria Paré, Fréderic Herring, Elizabeth Gauthier, Rémy Jean, Dominique Beaulieu, Jean-François BMC Cancer Research Article BACKGROUND: Integrins are known to be important contributors to cancer progression. We have previously shown that the integrin β4 subunit is up-regulated in primary colon cancer. Its partner, the integrin α6 subunit, exists as two different mRNA splice variants, α6A and α6B, that differ in their cytoplasmic domains but evidence for distinct biological functions of these α6 splice variants is still lacking. METHODS: In this work, we first analyzed the expression of integrin α6A and α6B at the protein and transcript levels in normal human colonic cells as well as colorectal adenocarcinoma cells from both primary tumors and established cell lines. Then, using forced expression experiments, we investigated the effect of α6A and α6B on the regulation of cell proliferation in a colon cancer cell line. RESULTS: Using variant-specific antibodies, we observed that α6A and α6B are differentially expressed both within the normal adult colonic epithelium and between normal and diseased colonic tissues. Proliferative cells located in the lower half of the glands were found to predominantly express α6A, while the differentiated and quiescent colonocytes in the upper half of the glands and surface epithelium expressed α6B. A relative decrease of α6B expression was also identified in primary colon tumors and adenocarcinoma cell lines suggesting that the α6A/α6B ratios may be linked to the proliferative status of colonic cells. Additional studies in colon cancer cells showed that experimentally restoring the α6A/α6B balance in favor of α6B caused a decrease in cellular S-phase entry and repressed the activity of c-Myc. CONCLUSION: The findings that the α6Bβ4 integrin is expressed in quiescent normal colonic cells and is significantly down-regulated in colon cancer cells relative to its α6Aβ4 counterpart are consistent with the anti-proliferative influence and inhibitory effect on c-Myc activity identified for this α6Bβ4 integrin. Taken together, these findings point out the importance of integrin variant expression in colon cancer cell biology. BioMed Central 2009-07-09 /pmc/articles/PMC2715428/ /pubmed/19586553 http://dx.doi.org/10.1186/1471-2407-9-223 Text en Copyright ©2009 Dydensborg et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dydensborg, Anders Bondo
Teller, Inga C
Groulx, Jean-François
Basora, Nuria
Paré, Fréderic
Herring, Elizabeth
Gauthier, Rémy
Jean, Dominique
Beaulieu, Jean-François
Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
title Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
title_full Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
title_fullStr Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
title_full_unstemmed Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
title_short Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
title_sort integrin α6bβ4 inhibits colon cancer cell proliferation and c-myc activity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715428/
https://www.ncbi.nlm.nih.gov/pubmed/19586553
http://dx.doi.org/10.1186/1471-2407-9-223
work_keys_str_mv AT dydensborgandersbondo integrina6bb4inhibitscoloncancercellproliferationandcmycactivity
AT telleringac integrina6bb4inhibitscoloncancercellproliferationandcmycactivity
AT groulxjeanfrancois integrina6bb4inhibitscoloncancercellproliferationandcmycactivity
AT basoranuria integrina6bb4inhibitscoloncancercellproliferationandcmycactivity
AT parefrederic integrina6bb4inhibitscoloncancercellproliferationandcmycactivity
AT herringelizabeth integrina6bb4inhibitscoloncancercellproliferationandcmycactivity
AT gauthierremy integrina6bb4inhibitscoloncancercellproliferationandcmycactivity
AT jeandominique integrina6bb4inhibitscoloncancercellproliferationandcmycactivity
AT beaulieujeanfrancois integrina6bb4inhibitscoloncancercellproliferationandcmycactivity